Eczema atópico na criança e no adulto

 

Cristina Claro*

*Assistente Hospitalar Graduada de Dermatologia. Centro de Dermatologia Médico-cirúrgica de Lisboa

 

Correspondência

 

Resumo

O eczema atópico é uma doença inflamatória da pele, crónica e recorrente, de incidência crescente. Muitas vezes de controlo difícil, requer a estreita colaboração entre as diversas especialidades com ela envolvidas.

Serão brevemente abordadas a epidemiologia e a etiopatogenia desta doença, e realçadas a clínica e a terapêutica, salientando-se aspectos práticos considerados importantes para o correcto acompanhamento dos doentes.

Palavras-chave: Eczema Atópico; Criança; Adulto.

 

Abstract

A topic Dermatitis in children and adults

A topic dermatitis is a chronic relapsing inflammatory skin condition, of increasing incidence. Strict collaboration between the specialities that deal with this illness is essential.

The epidemiology, aetiology and pathogenesis of atopic dermatitis will be briefly approached; the clinical features of the disease and some practical aspects of its treatment will be addressed.

Keywords: Atopic Dermatitis; Children; Adults.

 

Texto completo disponível apenas em PDF.

Full text only available in PDF format.

 

Referências Bibliográficas

1. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999 Jan; 103 (1 Pt 1): 125-38.        [ Links ]

2. Trepka MJ, Heinrich J, Wichmann HE. The epidemiology of atopic diseases in Germany: an east-west comparison. Rev Environ Health 1996 Jul-Sep; 11 (3): 119-31.

3. Kang K, Polster AM, Nedorost ST, et al. Atopic dermatitis. In: Bolognia JL, Jorizzo JL, Rapini RP, et al., editors. Dermatology. New York: Mosby; 2003. p. 199.

4. Eichenfield LF, Hanifin JM, Beck LA, Lemanske RF Jr, Sampson HA, Weiss ST, et al. Atopic dermatitis and asthma: parallels in the evolution of treatment. Pediatrics 2003 Mar; 111 (3): 608-16.

5. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993 May; 28 (5 Pt 1): 719-23.

6. Sandilands A, Smith FJ, Irvine AD, McLean WH. Fillagrin’s fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 2007 Jun; 127 (6): 1282-4.

7. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009 May; 123 (5): e808-14.

8. Eller E, Kjaer HF, Høst A, Andersen KE, Bindslev-Jensen C. Food alergy and food sensitization in early childhood: results from the DARC cohort. Allergy 2009 Jul; 64 (7): 1023-9.

9. Hon KL, Leung TF, Ching G, Chow CM, Luk V, Ko WS, et al. Patterns of food and aeroallergen sensitization in childhood eczema. Acta Paediatr 2008 Dec; 97 (12): 1734-7.

10. Pónayi G, Hidvégi B, Németh I, Sas A, Tamesvári E, Kárpáti S. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol 2008 Nov; 22 (11): 1346-55.

11. Hanifin JM, Cooper KD, Ho VC, Kang S, Kreftchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)/American Academy of Dermatology Association "Administrative Regulations for Evidence-Based Clinical Practice Guidelines". J Am Acad Dermatol 2004 Mar; 50 (3): 391-404.

12. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005 Mar 5; 330 (7490): 516.

13. Berger TG, Duvic M, Van Voorhees AS, VanBeek MJ, Frieden IJ; American Academy of Dermatology Association Task Force. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Task Force. J Am Acad Dermatol 2006 May; 54 (5): 818-23.

 

Conflitos de interesse

Declaro para os devidos efeitos não haver qualquer conflito de interesses para a realização deste trabalho, bem como não ter havido qualquer financiamento para a realização do mesmo.

 

ENDEREÇO PARA CORRESPONDÊNCIA

Cristina Claro

Av. Guerra Junqueiro,13-2.^o esq. 1000-166 Lisboa

cristina.claro@netcabo.pt

 

Recebido em 05/12/2010

Aceite para publicação em 15/02/2011